FDA approves new drug indication for Forteo
July 28th 2009On July 23, Eli Lilly and Company announced the Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO to treat osteoporosis associated with sustained, systemic glucocorticoid therapy in men and women at high risk of fracture.
AACP session promotes humanity in pharmacy
July 20th 2009Carolyn Brackett, PharmD, Associate Professor of Clinical Pharmacy at Ohio State University?s College of Pharmacy believes it?s possible to bring more humanity and human-to-human interaction to pharmacy ? regardless of the area in which they practice.
FDA approves new drug for enzyme replacement
May 6th 2009The U.S. Food and Drug Administration announced recently the approval of Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods.
Wyeth liability case advances in California
March 19th 2009California may be moving toward a new form of liability. The state Supreme Court declined to hear an appeal from Wyeth in a case the held the drug maker liable for injuries caused by generic versions of Reglan (metoclopramide) made by another manufacturer.
Study: Pharmacists most likely to catch medication errors
March 9th 2009Most medication errors in primary care practices are prescribing errors and, while a majority of those reach the patient, pharmacists are most likely to intercept the mistakes, according to a new study by the Agency for Healthcare Research and Quality.